Clinical Trial Update: A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of AZD2389 in healthy participants, evaluating administration alone and in combination with quinidine; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• AZD2389

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Chronic Liver Disease, Healthy Participants | Phase 1 | Status: COMPLETED